Handel nachbörslich: 25.68 0.21 +0.82%

Bicara Therapeutics Inc (BCAX)

Bicara Therapeutics Inc Aktie (BCAX) Neueste Nachrichten

Bicara Therapeutics Inc (BCAX)

Bicara Therapeutics Inc Aktie (BCAX) Neueste Nachrichten

Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors - Barron's

With IPO, have the capital and resources for clinical studies: Bicara CEO - The Economic Times

Bicara Therapeutics Rings the Opening Bell - Nasdaq

Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN

TPG GP A, LLC Acquires New Stake in Bicara Therapeutics Inc - GuruFocus.com

James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World

Ra Capital Management, L.P. Purchases 1,833,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World

Ra capital executives buy Bicara Therapeutics shares for $32.99m By Investing.com - Investing.com Canada

Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India

Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com

Ra capital executives buy Bicara Therapeutics shares for $32.99m By Investing.com - Investing.com UK

FMR LLC Acquires New Stake in Bicara Therapeutics Inc - Yahoo Finance

FMR LLC Acquires New Stake in Bicara Therapeutics Inc - GuruFocus.com

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - MSN

Deerfield entities buy Bicara Therapeutics shares worth $1.26m By Investing.com - Investing.com Australia

Deerfield entities buy Bicara Therapeutics shares worth $1.26m - Investing.com

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Yahoo Finance

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Pharmaceutical Technology

MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip

Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - StockTitan

Bicara, MBX Bio lead gainers as biotech trio makes trading debut - MSN

TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN

Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News

Trio of first-day pops may bode well for biotech IPO window - BioCentury

Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada

Biotech IPO Shares Climb in Debuts After Deals Upsized - Bloomberg

2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360

TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - KFGO

Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch

3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - MedCity News

Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals

Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha

TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - Reuters

Biotech IPO Shares Climb in Debuts After Deals Upsized - BNN Bloomberg

TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - WDKE 96.1 Duke FM

TPG-backed Bicara Therapeutics raises $315 mln in US IPO - Reuters

Two local biotechs go public, raising $540 million total - The Boston Globe

3 Biotechs Seek Over $700M in Renewed IPO Rush - BioSpace

Two local biotechs pull in $540M in IPOs - The Business Journals

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Yahoo Finance

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - Bloomberg

Three biotechs raise $700M in rare burst of IPO activity - BioPharma Dive

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - ForexTV.com

BCAXBicara Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - StockTitan

Bicara Therapeutics Announces Pricing Of Upsized Initial Public Offering - XM

Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewswire

Three biotechs raise $700M in rare burst of IPO activity - Yahoo Finance

Boston biotech increases target for pending IPO - The Business Journals

Bicara Therapeutics targets $265 million proceeds in upsized US IPO - KFGO

Bicara Therapeutics targets $265 mln proceeds in upsized US IPO - Reuters

IPO Roundup: Bicara Therapeutics, Kairos Pharma and more - MSN

Two Massachusetts biotech IPOs expected this week - The Business Journals

IPO Roundup: Bicara Therapeutics, Kairos Pharma and more (NYSEARCA:IPO) - Seeking Alpha

Bicara Therapeutics Aims For $200 Million IPO For Cancer Treatment Advance (NASDAQ:BCAX) - Seeking Alpha

Bicara Therapeutics (BCAX) to Raise $201 Million in IPO - Defense World

Bicara Therapeutics aims for up to $828 million valuation in U.S. IPO - MSN

Bicara Therapeutics Files for 11.765M Share IPO at $16-$18/sh - Investing.com Canada

Ähnlich wie BCAX